In vitro and in vivo T cell responses in mice during bronchopulmonary infection with mucoid Pseudomonas aeruginosa

Clinical and Experimental Immunology

Volumn 99, Issue 1, 1995, Pages 98-105

  Stevenson, M M ^a   Kondratieva, T K ^a   Apt, A S ^a   Tam, M F ^a   Skamene, E ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

cystic fibrosis; mice; Pseudomonas aeruginosa; T cells

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CYSTIC FIBROSIS; DELAYED HYPERSENSITIVITY; FEMALE; HOST RESISTANCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; T LYMPHOCYTE;

EID: 0028939692     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1995.tb03478.x     Document Type: Article

References (32)

1. J Pediatr Doggett 68 215 1966 10.1016/S0022-3476(66)80152-X An atypical Pseudomonas aeruginosa associated with cystic fibrosis of the pancreas
2. Infect Immun Doggett 6 628 1972 10.1128/iai.6.4.628-635.1972 Pseudomonas aeruginosa: immune status in patients with cystic fibrosis
3. A vicious cycle that does more harm than good? Clin Rev Allergy Berger 9 119 1991 Inflammation in the lung in cystic fibrosis
4. Infect Immun Sorensen 18 735 1977 10.1128/iai.18.3.735-740.1977 Cellular immunity to bacteria: impairment of in vitro lymphocyte responses to Pseudomonas aeruginosa in cystic fibrosis patients
5. J Pediatr Sorensen 93 201 1978 10.1016/S0022-3476(78)80496-X Lymphocyte responsiveness to Pseudomonas aeruginosa in cystic fibrosis: relationship to status of pulmonary disease in sibling pairs
6. Infect Immun Sorensen 23 398 1979 10.1128/iai.23.2.398-402.1979 Defective cellular immunity to Gram-negative bacteria in cystic fibrosis patients
7. Am Rev Respir Dis Sorensen 123 37 1981 Changes in lymphocyte reactivity to Pseudomonas aeruginosa in hospitalized patients with cystic fibrosis
8. Am Rev Respir Dis Cash 119 453 1979 A rat model of chronic respiratory infection with Pseudomonas aeruginosa
9. J Clin Invest Pennington 68 1140 1981 10.1172/JCI110358 Active immunization with lipopolysaccharide Pseudomonas antigen for chronic Pseudomonas bronchopneumonia in guinea pigs
10. Infect Immun Thomassen 45 741 1984 10.1128/iai.45.3.741-747.1984 Pulmonary cellular response to chronic irritation and chronic Pseudomonas aeruginosa pneumonia in cats
11. Pediatric Res Starke 22 686 1987 10.1203/00006450-198712000-00017 A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia
12. Science Pier 249 537 1990 10.1126/science.2116663 Protection against mucoid Pseudomonas aeruginosa in rodent models of endobronchial infections
13. Science Snouwaert 257 1083 1992 10.1126/science.257.5073.1083 An animal model for cystic fibrosis made by gene targeting
14. Nature Dorin 359 211 1992 10.1038/359211a0 Cystic fibrosis in the mouse by targeted insertional mutagenesis
15. Clin Exp Immunol Holt 66 188 1986 Extraction of immune and inflammatory cells from human lung parenchyma: evaluation of enzymatic digestion procedure
16. Immunology Apt 73 173 1991 Regulation of T-cell proliferative responses by cells from solid lung tissue of M. tuberculosis-infected mice
17. Eur J Immunol Karasuyama 18 97 1988 10.1002/eji.1830180115 Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors
18. Regional Immunol 1990 Berk 3 186 1991 Antibody hyporesponsiveness in resistant BALB/c mice intracorneally infected with Pseudomonas aeruginosa
19. Infect Immun Porwoll 40 670 1983 10.1128/iai.40.2.670-674.1983 In vitro response of human T cells to Pseudomonas aeruginosa
20. J Immunol Chouaib 135 1172 1985 Prostagiandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression
21. J Exp Med Holt 177 397 1993 10.1084/jem.177.2.397 Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages
22. J Immunol Schleifer 151 5492 1993 Suppressor macrophages in African trypanosomes inhibit T cell proliferative responses by nitric oxide and prostaglandin
23. Acta Pathol Microbiol Scan Sect C Høiby 262 Suppl. 3 1977 Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Psuedomonas aeruginosa precipitins determined by means of crossed immunoelectro phoresis. A survey
24. J Infect Dis Klinger 138 49 1978 10.1093/infdis/138.1.49 Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: demonstration by radioimmunoassay
25. Infect Immun Doring 42 197 1983 10.1128/iai.42.1.197-201.1983 Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis
26. J Clin Lab Immunol Lagacé 30 7 1989 Circulating immune complexes, antibodies to Pseudomonas aeruginosa, and pulmonary status in cystic fibrosis
27. Immunology Kawabe 76 72 1992 Immunosuppressive activity induced by nitric oxide in culture supernatant of activated rat alveolar macrophages
28. J Immunol Mills 146 2719 1991 Molecular basis of “suppressor” macrophages. Arginine metabolism via nitric oxide synthetase pathway
29. Annu Rev Immunol Sher 10 385 1992 10.1146/annurev.iy.10.040192.002125 Regulation of immunity to parasites by T cells and T cell-derived cytokines
30. Immunol Today Clerici 14 107 1993 10.1016/0167-5699(93)90208-3 A Th1-Th2 switch is a critical step in the etiology of HIV infection
31. Pulmonology Moss S9 289 1993 Is CF a Th2 immuno-inflammatory disease
32. J Allergy Clin Immunol Greally 93 100 1994 10.1016/0091-6749(94)90238-0 Atopic children with cystic fibrosis have increased urinary leukotriene E4 concentrations and more severe pulmonary disease